GlaxoSmithKline today announced that the Stiefel plant in Sligo will remain open and will receive an investment of €10 million, supported by the IDA

In 2009 the company announced the phased closure of the plant. It will now stay open, and though 60 of the remaining 180 jobs will go initially, GSK says it hopes to re-recruit most of them by 2014.

The project is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland and will enhance the plant’s technical expertise and capacity.

The plant, which had been scheduled to close next year, will become a dedicated Stiefel consumer products supply site.

“The flexibility, productivity and commitment of GSK staff in Sligo have been important factors in this decision,” said a company spokeswoman.